MiR-15b-5p is Involved in Doxorubicin-Induced Cardiotoxicity via Inhibiting Bmpr1a Signal in H9c2 Cardiomyocyte

  • Guo-xing Wan
  • Lan Cheng
  • Hai-lun Qin
  • Yun-zhang Zhang
  • Ling-yu Wang
  • Yong-gang Zhang


The wide use of anthracyclines represented by doxorubicin (DOX) has benefited cancer patients, yet the clinical application is limited due to its cardiotoxicity. Although numerous evidences have supported a role of microRNAs (miRNAs) in DOX-induced myocardial damage, the exact etiology and pathogenesis remain largely obscure. In this study, we focused on the role of miR-15b-5p in DOX-induced cardiotoxicity. We employed a public miRNA and gene microarray to screen differentially expressed miRNAs (DEMs) and differentially expressed genes (DEGs) in rat cardiomyocytes, and 33 DEMs including miR-15b-5p and 237 DEGs including Bmpr1a and Gata4 were identified. The Gene ontology (GO) and pathway enrichment analysis of 237 DEGs indicated that the DEGs were mainly enriched in heart development and ALK pathway in cardiomyocyte which included the main receptor Bmpr1a and transcription factor Gata4. The up-regulated miR-15b-5p and down-regulated Bmpr1a and Gata4 mRNA expressions were further validated in H9c2 cardiomyocytes exposed to DOX. Moreover, the results showed overexpression of miR-15b-5p or inhibition of Bmpr1a may enhance the DOX-induced apoptosis, oxidative stress and mitochondria damage in H9c2 cardiomyocytes. The Bmpr1a was suggested as a potential target of miR-15b-5p by bioinformatics prediction. We further verified the negatively regulatory effect of miR-15b-5p on Bmpr1a signaling. Moreover, we also confirmed that overexpression of miR-15b-5p may exacerbate the DOX-induced apoptosis of H9c2 cardiomyocytes by affecting the protein expression ratio of Bcl-2/Bax and Akt activation, while this pro-apoptotic effect was able to be suppressed by Bmpr1a agonist. Collectively, the results suggest that miR-15b-5p is likely involved in doxorubicin-induced cardiotoxicity via inhibiting Bmpr1a signaling in H9c2 cardiomyocytes. Our study provides a novel insight for investigating DOX-induced cardiotoxicity.


MiR-15b-5p Bmpr1a Doxorubicin Cardiotoxicity 


Compliance with Ethical Standards

Conflict of interest

The authors declare that they have no conflict of interest with respect to the research, authorship, and/or publication of this article.


  1. 1.
    Roca-Alonso, L., Castellano, L., Mills, A., Dabrowska, A. F., Sikkel, M. B., Pellegrino, L.,et al (2015). Myocardial MiR-30 downregulation triggered by doxorubicin drives alterations in beta-adrenergic signaling and enhances apoptosis. Cell Death & Disease, 6, e1754.CrossRefGoogle Scholar
  2. 2.
    Zhao, L., Qi, Y., Xu, L., Tao, X., Han, X., Yin, L.,et al (2018). MicroRNA-140-5p aggravates doxorubicin-induced cardiotoxicity by promoting myocardial oxidative stress Via targeting Nrf2 and Sirt2. Redox Biology, 15, 284–296.CrossRefGoogle Scholar
  3. 3.
    Mukhopadhyay, P., Rajesh, M., Batkai, S., Kashiwaya, Y., Hasko, G., Liaudet, L.,et al (2009). Role of superoxide, nitric oxide, and peroxynitrite in doxorubicin-induced cell death in vivo and in vitro. American Journal of Physiology Heart and Circulatory Physiology, 296, H1466–H1483.CrossRefGoogle Scholar
  4. 4.
    Zhang, S., Liu, X., Bawa-Khalfe, T., Lu, L. S., Lyu, Y. L., Liu, L. F.,et al (2012). Identification of the molecular basis of doxorubicin-induced cardiotoxicity. Nature Medicine, 18, 1639–1642.CrossRefGoogle Scholar
  5. 5.
    Pecoraro, M., Del, P. M., Marzocco, S., Sorrentino, R., Ciccarelli, M., Iaccarino, G.,et al (2016). Inflammatory Mediators in a short-time mouse model of doxorubicin-induced cardiotoxicity. Toxicology and Applied Pharmacology, 293, 44–52.CrossRefGoogle Scholar
  6. 6.
    Wang, J. X., Zhang, X. J., Feng, C., Sun, T., Wang, K., Wang, Y.,et al (2015). MicroRNA-532-3p regulates mitochondrial fission through targeting apoptosis repressor with caspase recruitment domain in doxorubicin cardiotoxicity. Cell Death & Disease, 6, e1677.CrossRefGoogle Scholar
  7. 7.
    Liu, L. F., Liang, Z., Lv, Z. R., Liu, X. H., Bai, J., Chen, J.,et al (2012). MicroRNA-15a/b are up-regulated in response to myocardial ischemia/reperfusion injury. Journal of Geriatric Cardiology, 9, 28–32.CrossRefGoogle Scholar
  8. 8.
    Liu, L., Zhang, G., Liang, Z., Liu, X., Li, T., Fan, J.,et al (2014). MicroRNA-15b enhances hypoxia/reoxygenation-induced apoptosis of cardiomyocytes via a mitochondrial apoptotic pathway. Apoptosis, 19, 19–29.CrossRefGoogle Scholar
  9. 9.
    Roy, S., Banerjee, J., Gnyawali, S. C., Khanna, S., He, G., Pfeiffer, D.,et al (2013). Suppression of induced microrna-15b prevents rapid loss of cardiac function in a dicer depleted model of cardiac dysfunction. PLoS ONE, 8, e66789.CrossRefGoogle Scholar
  10. 10.
    Nishi, H., Ono, K., Iwanaga, Y., Horie, T., Nagao, K., Takemura, G.,et al (2010). MicroRNA-15b modulates cellular ATP levels and degenerates mitochondria via Arl2 in neonatal rat cardiac myocytes. Journal of Biological Chemistry, 285, 4920–4930.CrossRefGoogle Scholar
  11. 11.
    Jain, S., Wei, J., Mitrani, L. R., & Bishopric, N. H. (2012). Auto-acetylation stabilizes P300 in cardiac myocytes during acute oxidative stress, promoting STAT3 accumulation and cell survival. Breast Cancer Research and Treat, 135, 103–114.CrossRefGoogle Scholar
  12. 12.
    Wan, G., Ji, L., Xia, W., Cheng, L., & Zhang, Y. (2018). Screening genes associated with elevated neutrophiltolymphocyte ratio in chronic heart failure. Molecular Medicine Reports, 18, 1415–1422.Google Scholar
  13. 13.
    Ritchie, M. E., Phipson, B., Wu, D., Hu, Y., Law, C. W., Shi, W.,et al (2015). Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Research, 43, e47.CrossRefGoogle Scholar
  14. 14.
    Yu, G., Wang, L. G., Han, Y., & He, Q. Y. (2012). ClusterProfiler: An R Package for comparing biological themes among gene clusters. Omics-A Journal of Integrative Biology, 16, 284–287.CrossRefGoogle Scholar
  15. 15.
    Zhao, L., Tao, X., Qi, Y., Xu, L., Yin, L., & Peng, J. (2018). Protective effect of dioscin against doxorubicin-induced cardiotoxicity via adjusting microRNA-140-5p-mediated myocardial oxidative stress. Redox Biology, 16, 189–198.CrossRefGoogle Scholar
  16. 16.
    Zhang, A., Sheng, Y., & Zou, M. (2017). Antiproliferative activity of alisol B in MDA-MB-231 cells is mediated by apoptosis, dysregulation of mitochondrial functions, cell cycle arrest and generation of reactive oxygen species. Biomedicine & Pharmacotherapy, 87, 110–117.CrossRefGoogle Scholar
  17. 17.
    Holmgren, G., Synnergren, J., Andersson, C. X., Lindahl, A., & Sartipy, P. (2016). MicroRNAs as potential biomarkers for doxorubicin-induced cardiotoxicity. Toxicology in Vitro, 34, 26–34.CrossRefGoogle Scholar
  18. 18.
    Chaudhari, U., Nemade, H., Gaspar, J. A., Hescheler, J., Hengstler, J. G., & Sachinidis, A. (2016). MicroRNAs as early toxicity signatures of doxorubicin in human-induced pluripotent stem cell-derived cardiomyocytes. Archives of Toxicology, 90, 3087–3098.CrossRefGoogle Scholar
  19. 19.
    Ruggeri, C., Gioffre, S., Achilli, F., Colombo, G. I., & D’Alessandra, Y. (2018). Role of microRNAs in doxorubicin-induced cardiotoxicity: An overview of preclinical models and cancer patients. Heart Failure Reviews, 23, 109–122.CrossRefGoogle Scholar
  20. 20.
    Gaussin, V., Morley, G. E., Cox, L., Zwijsen, A., Vance, K. M., Emile, L.,et al (2005). Alk3/Bmpr1a receptor is required for development of the atrioventricular canal into valves and annulus fibrosus. Circulation Research, 97, 219–226.CrossRefGoogle Scholar
  21. 21.
    Breckpot, J., Tranchevent, L. C., Thienpont, B., Bauters, M., Troost, E., Gewillig, M.,et al (2012). BMPR1A is a candidate gene for congenital heart defects associated with the recurrent 10Q22q23 deletion syndrome. European Journal of Medical Genetics, 55, 12–16.CrossRefGoogle Scholar
  22. 22.
    El-Bizri, N., Wang, L., Merklinger, S. L., Guignabert, C., Desai, T., Urashima, T.,et al (2008). Smooth muscle protein 22Alpha-mediated patchy deletion of Bmpr1a impairs cardiac contractility but protects against pulmonary vascular remodeling. Circulation Research, 102, 380–388.CrossRefGoogle Scholar
  23. 23.
    Kobayashi, S., Volden, P., Timm, D., Mao, K., Xu, X., & Liang, Q. (2010). Transcription factor GATA4 inhibits doxorubicin-induced autophagy and cardiomyocyte death. Journal of Biological Chemistry, 285, 793–804.CrossRefGoogle Scholar
  24. 24.
    Kobayashi, S., Lackey, T., Huang, Y., Bisping, E., Pu, W. T., Boxer, L. M.,et al (2006). Transcription factor Gata4 regulates cardiac BCL2 gene expression in vitro and in vivo. Faseb Journal, 20, 800–802.CrossRefGoogle Scholar
  25. 25.
    Wu, Y., Zhou, X., Huang, X., Xia, Q., Chen, Z., Zhang, X.,et al (2016). Pax8 plays a pivotal role in regulation of cardiomyocyte growth and senescence. Journal of Cellular and Molecular Medicine, 20, 644–654.CrossRefGoogle Scholar
  26. 26.
    Yang, D., Lai, D., Huang, X., Shi, X., Gao, Z., Huang, F.,et al (2012). The defects in development and apoptosis of cardiomyocytes in mice lacking the transcriptional factor Pax-8. International Journal of Cardiology, 154, 43–51.CrossRefGoogle Scholar
  27. 27.
    Sui, X., Li, D., Qiu, H., Gaussin, V., & Depre, C. (2009). Activation of the bone morphogenetic protein receptor by H11kinase/Hsp22 promotes cardiac cell growth and survival. Circulation Research, 104, 887–895.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  • Guo-xing Wan
    • 1
  • Lan Cheng
    • 1
  • Hai-lun Qin
    • 1
  • Yun-zhang Zhang
    • 1
  • Ling-yu Wang
    • 1
  • Yong-gang Zhang
    • 1
  1. 1.Department of CardiologyThe Second Affiliated Hospital of Shantou University Medical CollegeShantouPeople’s Republic of China

Personalised recommendations